Success Metrics

Clinical Success Rate

81.8%

Based on 9 completed trials

Completion Rate

82%(9/11)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Terminated

2(17%)

Phase Distribution

Ph phase_2

25%

Ph phase_1

75%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution12 total trials

Phase 1Safety & dosage

9(75.0%)

Phase 2Efficacy & side effects

3(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

81.8%

9 of 11 finished

Non-Completion Rate

18.2%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(9)

Terminated(2)

Other(1)

Detailed Status

Completed9

Terminated2

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

81.8%

Most Advanced

Phase 2

Trials by Phase

Phase 19 (75.0%)

Phase 23 (25.0%)

Trials by Status

completed975%

terminated217%

unknown18%

Recent Activity

0 active trials

Showing 5 of 12

completedphase_1

Gene Therapy in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Surgically Removed

NCT00003649

completedphase_1

Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer

NCT00003450

completedphase_1

Gene Therapy in Treating Patients With Recurrent Malignant Gliomas

NCT00004041

unknownphase_2

Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer

NCT00003257

completedphase_2

Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer

NCT00044993

View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials

NCT00003649Phase 1

Gene Therapy in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Surgically Removed

Completed

NCT00003450Phase 1

Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer

Completed

NCT00004041Phase 1

Gene Therapy in Treating Patients With Recurrent Malignant Gliomas

Completed

NCT00003257Phase 2

Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer

Unknown

NCT00044993Phase 2

Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer

Completed

NCT00003588Phase 1

Gene Therapy in Treating Patients With Ovarian Cancer

Completed

NCT00004038Phase 1

Gene Therapy Plus Chemotherapy in Treating Patients With Breast Cancer

Completed

NCT00003147Phase 1

Gene Therapy in Treating Patients With Cancer of The Liver

Terminated

NCT00064103Phase 1

Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx

Completed

NCT00003167Phase 1

Gene Therapy in Treating Patients With Advanced Bladder Cancer

Completed

NCT00017173Phase 2

S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or Throat

Terminated

NCT00004225Phase 1

Gene Therapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer

Completed

All 12 trials loaded

Drug Details

Intervention Type: BIOLOGICAL
Total Trials: 12